2018
DOI: 10.1016/j.atherosclerosis.2018.01.027
|View full text |Cite
|
Sign up to set email alerts
|

Selective inhibition of endothelial NF-κB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
32
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(33 citation statements)
references
References 44 publications
1
32
0
Order By: Relevance
“…hibition of the NF-κB transcription factor appears to be beneficial in reducing cardiovascular-related complications including cardiac hypertrophy (Yu et al, 2015), cardiac fibrosis (Wang et al, 2018) and atherosclerosis (Song et al, 2018). In parallel, the role of phenolic acids in regulating the NF-κB transcription factor has also been reported previously (Cichocki et al, 2010;Wang et al, 2018).…”
Section: The Role Of Inflammation In Cardiovascular Diseasesmentioning
confidence: 75%
“…hibition of the NF-κB transcription factor appears to be beneficial in reducing cardiovascular-related complications including cardiac hypertrophy (Yu et al, 2015), cardiac fibrosis (Wang et al, 2018) and atherosclerosis (Song et al, 2018). In parallel, the role of phenolic acids in regulating the NF-κB transcription factor has also been reported previously (Cichocki et al, 2010;Wang et al, 2018).…”
Section: The Role Of Inflammation In Cardiovascular Diseasesmentioning
confidence: 75%
“…The effects of IH on inflammation are controversial. 24,25 However, LOX has been reported to inhibit inflammation. 26 Thus, in this study, the anti-inflammatory effect of IH in BAPN induced TAD mice may be attributed to increased expression of HIF-1a and LOX.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have indicated that the relationship of APRIL and NF-KB signaling pathway activation is one of a complex interactive, APRIL could induce inflammatory activation by the activation of NF-KB signaling pathway [15,16], and conversely, NF-KBdependent pathways can influence APRIL secretion [17,18]. A large body of evidence, including experimental and clinical studies, have demonstrated that the activation of NF-KB-dependent inflammatory pathways by intermittent hypoxia and reoxygenation in OSA may be an important molecular mechanism of cardiovascular complication [4,19,20]. Moreover, both RNA and protein expression of APRIL have been shown in human plaque lymphocytes and macrophages and plasma [37,38].…”
Section: Discussionmentioning
confidence: 99%
“…Current evidence suggests that APRIL could induce inflammatory activation by the activation of NF-KB signaling pathway [15,16], and conversely, NF-KB-dependent signaling pathways, in turn, can influence APRIL secretion [17,18]. The activation of NF-KB-dependent inflammatory pathways by intermittent hypoxia and reoxygenation in OSA may be an important molecular mechanism of cardiovascular complication [4,19,20]. In addition, several studies showed that monocyte chemotactic protein-1 (MCP-1) and Lselectin as inflammation mediators can be regulated via the activation of NF-KB signaling pathways, and they were significantly elevated in patients with OSA [21][22][23][24].…”
mentioning
confidence: 99%